278 related articles for article (PubMed ID: 27789397)
1. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.
Kele M; Day K; Rönnholm H; Schuster J; Dahl N; Falk A
Stem Cell Res; 2016 Nov; 17(3):474-478. PubMed ID: 27789397
[TBL] [Abstract][Full Text] [Related]
2. Derivation of human iPS cell lines from monozygotic twins in defined and xeno free conditions.
Uhlin E; Rönnholm H; Day K; Kele M; Tammimies K; Bölte S; Falk A
Stem Cell Res; 2017 Jan; 18():22-25. PubMed ID: 28395796
[TBL] [Abstract][Full Text] [Related]
3. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
[TBL] [Abstract][Full Text] [Related]
4. Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2017 Jan; 18():41-44. PubMed ID: 28395801
[TBL] [Abstract][Full Text] [Related]
5. Generation of human iPSCs from urine derived cells of a non-affected control subject.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2017 Jan; 18():33-36. PubMed ID: 28395799
[TBL] [Abstract][Full Text] [Related]
6. Characterization of iPSCs derived from dermal fibroblasts from a healthy 19year old female.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):597-599. PubMed ID: 27934589
[TBL] [Abstract][Full Text] [Related]
7. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dermal fibroblast-derived iPSCs from a patient with high grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):568-571. PubMed ID: 27789412
[TBL] [Abstract][Full Text] [Related]
9. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease.
Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L
Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
[TBL] [Abstract][Full Text] [Related]
11. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
[TBL] [Abstract][Full Text] [Related]
12. A feeder- and xeno-free human induced pluripotent stem cell line obtained from primary human dermal fibroblasts with epigenetic repression of reprogramming factors expression: GPCCi001-A.
Lach MS; Wroblewska JP; Augustyniak E; Kulcenty K; Suchorska WM
Stem Cell Res; 2017 Apr; 20():34-37. PubMed ID: 28395738
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cell line from foreskin fibroblasts.
Skrzypczyk A; Giri S; Bader A
Stem Cell Res; 2016 Nov; 17(3):572-575. PubMed ID: 27789413
[TBL] [Abstract][Full Text] [Related]
14. Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene.
Martí S; León M; Orellana C; Prieto J; Ponsoda X; López-García C; Vílchez JJ; Sevilla T; Torres J
Stem Cell Res; 2017 Jan; 18():1-4. PubMed ID: 28395795
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
Xiong K; Zhou Y; Hyttel P; Bolund L; Freude KK; Luo Y
Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
[TBL] [Abstract][Full Text] [Related]
16. Generation of human control iPS cell line CHOPWT10 from healthy adult peripheral blood mononuclear cells.
Maguire JA; Gagne AL; Jobaliya CD; Gandre-Babbe S; Gadue P; French DL
Stem Cell Res; 2016 Mar; 16(2):338-41. PubMed ID: 27345999
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
[TBL] [Abstract][Full Text] [Related]
18. Generation of a clonal induced pluripotent stem cell (iPSC) line expressing the mutant MECP2 allele from a Rett Syndrome patient fibroblast line.
Hunihan L; Brown J; Cacace A; Fernandes A; Weston A
Stem Cell Res; 2017 Apr; 20():67-69. PubMed ID: 28395743
[TBL] [Abstract][Full Text] [Related]
19. Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):547-549. PubMed ID: 27789406
[TBL] [Abstract][Full Text] [Related]
20. Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with lymphedema-distichiasis syndrome (LDS) carrying an insertion-deletion complex mutation in the FOXC2 gene.
Itoh M; Kawagoe S; Okano HJ; Nakagawa H
Stem Cell Res; 2016 May; 16(3):611-3. PubMed ID: 27346194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
